Trends in research on nanomedicine in urologic cancer: a bibliometric and visualized analysis.

Xiaopeng Lan, Mei Feng, Lili Chen, Luchen Zhang, Chao Han, Yizhen Wang, Jilu Zheng, Xiaoyan Wang, Chunlei Liu, Ranlu Liu
Author Information
  1. Xiaopeng Lan: Department of Urology, Tianjin Medical University General Hospital, Tianjin, China.
  2. Mei Feng: Department of Urology, Qingdao Central Hospital, University of Health and Rehabilitation Sciences, Qingdao, 266042, People's Republic of China.
  3. Lili Chen: Department of Urology, Qingdao Central Hospital, University of Health and Rehabilitation Sciences, Qingdao, 266042, People's Republic of China.
  4. Luchen Zhang: Department of Urology, Qingdao Central Hospital, University of Health and Rehabilitation Sciences, Qingdao, 266042, People's Republic of China.
  5. Chao Han: Department of Urology, Qingdao Central Hospital, University of Health and Rehabilitation Sciences, Qingdao, 266042, People's Republic of China.
  6. Yizhen Wang: Department of Urology, Qingdao Central Hospital, University of Health and Rehabilitation Sciences, Qingdao, 266042, People's Republic of China.
  7. Jilu Zheng: Department of Urology, Qingdao Central Hospital, University of Health and Rehabilitation Sciences, Qingdao, 266042, People's Republic of China. zhengjilu1993@126.com.
  8. Xiaoyan Wang: Department of Urology, Qingdao Central Hospital, University of Health and Rehabilitation Sciences, Qingdao, 266042, People's Republic of China. 809651886@qq.com.
  9. Chunlei Liu: Department of Urology, Qingdao Central Hospital, University of Health and Rehabilitation Sciences, Qingdao, 266042, People's Republic of China. liuchunlei1969@126.com.
  10. Ranlu Liu: Department of Urology, Tianjin Medical University General Hospital, Tianjin, China. ranluliu@126.com.

Abstract

Increasing research efforts are focused on studying the synthesis and mechanisms of nanomedicine in urologic cancer. We performed a bibliometric study of the literature on nanomedicine in urologic cancer over the last 23 years, focusing on aspects such as researchers, institutions, nations, and keywords. We searched for papers in the Web of Science Core Collection from January 1, 2001, to December 29, 2023. Only reviews and original articles written in English were considered. A total of 2386 papers satisfied the given criteria for inclusion. The publications included in the study originated from 90 nations. The United States had the largest number of published papers, accounting for more than 31.01% of the total. The leading institution in this field is the Chinese Academy of Sciences, with a publishing output of 2.35%. Farokhzad, Omid C., is the most prolific author, with 21 articles, and has garnered the most citations, totaling 6271. The latest phrase to enter the top ten most common lists was "gold nanoparticles." We searched for papers in the Web of Science Core Collection from January 1, 2000, to November 28, 2023. Only reviews and original articles written in English were considered. This is the first bibliometric study of nanomedicine in urologic cancer. This article provides a comprehensive analysis of the current state of research on nanomedicine in urologic cancer over the last 23 years. On the basis of this study, future researchers can identify noteworthy publications, journals, and potential collaborators and explore cutting-edge research directions.

Keywords

References

  1. Scand J Urol Nephrol. 2002 Feb;36(1):34-9 [PMID: 12002355]
  2. J Urol. 2011 Aug;186(2):448-51 [PMID: 21680003]
  3. Arch Toxicol. 2024 Feb;98(2):577-578 [PMID: 38017292]
  4. Eur J Cancer. 2003 Sep;39(13):1866-71 [PMID: 12932664]
  5. Invest New Drugs. 2012 Apr;30(2):794-802 [PMID: 21174224]
  6. Clin Cancer Res. 2022 Nov 1;28(21):4820-4831 [PMID: 35921526]
  7. Eur Urol. 2023 Nov;84(5):473-483 [PMID: 37258363]
  8. J Nanobiotechnology. 2023 Jan 3;21(1):3 [PMID: 36597108]
  9. Nat Rev Cancer. 2023 Sep 8;: [PMID: 37684402]
  10. Clin Prostate Cancer. 2002 Jun;1(1):37-41 [PMID: 15046711]
  11. Mol Cancer Ther. 2019 Feb;18(2):323-334 [PMID: 30401695]
  12. Nat Mater. 2021 Nov;20(11):1469-1479 [PMID: 34226688]
  13. Biomaterials. 2018 May;164:38-53 [PMID: 29482062]
  14. Ann Oncol. 2017 Nov 01;28(11):2754-2760 [PMID: 28950297]
  15. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023 Mar;15(2):e1846 [PMID: 35979879]
  16. Invest New Drugs. 2011 Dec;29(6):1465-74 [PMID: 20499131]
  17. Int J Mol Sci. 2021 Apr 28;22(9): [PMID: 33925129]
  18. Crit Rev Oncol Hematol. 2023 Dec;192:104144 [PMID: 37748694]
  19. Acta Pharmacol Sin. 2021 Jul;42(7):1040-1054 [PMID: 33772141]
  20. Eur Urol. 2021 Dec;80(6):730-737 [PMID: 34088520]
  21. Lancet. 2021 Sep 18;398(10305):1075-1090 [PMID: 34370973]
  22. J Control Release. 2022 Jul;347:435-448 [PMID: 35537539]
  23. Mol Pharm. 2018 Sep 4;15(9):4214-4225 [PMID: 30024759]
  24. Lancet Oncol. 2024 Feb;25(2):156-157 [PMID: 38142700]
  25. Eur Urol. 2007 Dec;52(6):1653-61 [PMID: 17125906]
  26. CA Cancer J Clin. 2021 May;71(3):209-249 [PMID: 33538338]
  27. Urol Oncol. 2024 Apr;42(4):75-101 [PMID: 38161104]
  28. Biomed Pharmacother. 2022 Nov;155:113791 [PMID: 36271568]
  29. Biosensors (Basel). 2022 Sep 27;12(10): [PMID: 36290934]
  30. Semin Cancer Biol. 2022 Nov;86(Pt 2):873-885 [PMID: 35074509]
  31. J Natl Compr Canc Netw. 2020 Mar;18(3):329-354 [PMID: 32135513]
  32. Invest New Drugs. 2002 Aug;20(3):331-7 [PMID: 12201496]
  33. Curr Drug Metab. 2022;23(9):708-722 [PMID: 35713127]
  34. CA Cancer J Clin. 2023 Jan;73(1):17-48 [PMID: 36633525]
  35. ACS Appl Mater Interfaces. 2021 Mar 31;13(12):13990-14003 [PMID: 33739080]
  36. JAMA Oncol. 2020 Nov 01;6(11):1751-1758 [PMID: 32940628]
  37. PLoS One. 2021 Jul 21;16(7):e0253847 [PMID: 34288914]
  38. J Pharm Pharmacol. 2021 Mar 4;73(2):169-177 [PMID: 33793801]
  39. Plants (Basel). 2023 May 03;12(9): [PMID: 37176928]
  40. Onco Targets Ther. 2017 Feb 27;10:1247-1260 [PMID: 28280359]
  41. Chem Soc Rev. 2021 Apr 7;50(7):4541-4563 [PMID: 33625421]
  42. J Control Release. 2018 Apr 10;275:117-128 [PMID: 29474960]

Word Cloud

Created with Highcharts 10.0.0nanomedicineurologiccancerstudyresearchpapersbibliometricarticlesanalysislast23 yearsresearchersnationssearchedWebScienceCoreCollectionJanuary12023reviewsoriginalwrittenEnglishconsideredtotalpublicationsIncreasingeffortsfocusedstudyingsynthesismechanismsperformedliteraturefocusingaspectsinstitutionskeywords2001December292386satisfiedgivencriteriainclusionincludedoriginated90UnitedStateslargestnumberpublishedaccounting3101%leadinginstitutionfieldChineseAcademySciencespublishingoutput235%FarokhzadOmidCprolificauthor21garneredcitationstotaling6271latestphraseentertoptencommonlists"goldnanoparticles"2000November28firstarticleprovidescomprehensivecurrentstatebasisfuturecanidentifynoteworthyjournalspotentialcollaboratorsexplorecutting-edgedirectionsTrendscancer:visualizedBibliometricMultidisciplinaryNanomedicineResearchfrontierUrologic

Similar Articles

Cited By